TITLE

Domestic Patents - Questions You Should Ask Your Patent Attorney

AUTHOR(S)
Pershes, Robert; Wagner, Louis
PUB. DATE
August 2005
SOURCE
BioPharm International;Aug2005, Vol. 18 Issue 8, p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Explores the steps in seeking and managing a patent for pharmaceutical products in the U.S. Assessment on the suitability of a drug discovery to be patented; Consideration of the free use provisions of the teachings and protection contained in the patent; Factor posing literal infringement of the license.
ACCESSION #
17932849

 

Related Articles

  • The Shifting Landscape of Patent Licensing. Carter, Jennifer // BioPharm International;Sep2007, Vol. 20 Issue 9, p32 

    The article focuses on the issue concerning the Supreme Court ruling in the Midlmmune v. Genentech case shifted the landscape of patent licensing in an essential process. As its result, a patent licensee now can challenge the validity of a patent without having to breach the license first. It...

  • "Trust Me": Patent Offices in Developing Countries. Drahos, Peter // American Journal of Law & Medicine;2008, Vol. 34 Issue 2/3, p151 

    The article discusses the importance of having patent offices in developing countries. It notes on how patent rules are available for the structure and evolution of pharmaceutical markets as regarded by the patent provisions of the Agreement on Trade-Related Aspects of the Intellectual Property...

  • Have you got a licence?  // Life Science Today;Aug2000, Vol. 1 Issue 4, p8 

    Focuses on the competition of drug companies to license pharmaceutical compounds in Great Britain. Increase of the rate of licensing expenditures; Origin of blockbuster drugs marketed by top pharmaceutical companies; Accounts on the profitability of in-licensed products.

  • Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb. Borshell, Nigel; Dawkes, Adrian // Journal of Commercial Biotechnology;Jan2010, Vol. 16 Issue 1, p8 

    The 25 per cent rule of thumb is often quoted in the context of licensing royalty rates and, in particular, when deriving an appropriate rate of income due to a licensor for an individual asset. We have set out to conduct an in-depth analysis of historic market data from the pharmaceutical...

  • The licensing of DNA patents by US academic institutions: an empirical survey. Pressman, Lori; Burgess, Richard; Cook-Deegan, Robert M; McCormack, Stephen J; Nami-Wolk, Io; Soucy, Melissa; Walters, LeRoy // Nature Biotechnology;Jan2006, Vol. 24 Issue 1, p31 

    The article describes the academic DNA patent universe and presents the results of a federally funded survey of licensing practices at 19 of the 30 U.S. academic institutions that have received the largest number of DNA patents. The findings of the survey suggests that simple reports on...

  • Beware of the troll. Macdonald, Morag // Lawyer;9/26/2005, Vol. 19 Issue 37, p26 

    Explains why Europe needs to be prepared with patent troll, a phenomenon in which a company licenses out the patents and enforces them against those who refuse to take a license. Prevalence of the phenomenon in the United States; Reasons why Europe is less attractive to the business model of...

  • New Web Opportunities For IP Managers. Studt, Tim // R&D Magazine;Jun2000, Vol. 42 Issue 6, pE8 

    Provides information on Web tools available for intellectual property (IP) managers. Global leader in terms of the number of patents awarded; Tools that enable IP transactions to occur quickly; Companies that have developed Web-based marketplaces for the exchange of intellectual properties;...

  • THE INNOVATOR'S DILEMMA…. Williams, Russell // Inventors' Digest;Jan2008, Vol. 24 Issue 1, p30 

    The article focuses on filing provisional and non-provisional patents. Some factors to consider by inventors in deciding which type of patent should be filed are financial condition, stage of development and risk tolerance of the invention. It explains that non-provisional patent is known as a...

  • THE IMPACT OF INDUSTRIAL CHARACTERISTICS AND ORGANIZATIONAL CLIMATE ON KMS AND BIP-TAIWAN BIOSCIENCE INDUSTRY. Li-Ling Hsu // Journal of Computer Information Systems;Summer2006, Vol. 46 Issue 4, p8 

    The aim of this paper is to examine how the bioscience industry exploits KMS to effectively manage intellectual properly, especially patent documents. A majority of Taiwan's bioscience firms are small and medium-sized start-up companies that possess many valuable intellectual properties and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics